This website is intended for journalists outside the US/UK/Canada, who are interested in media information from Boehringer Ingelheim.

Top Stories



    Media Invite: ESMO 2014


    The Power of 140 Characters: When Social Media met the ESC Congress 2014

    Events and Initiatives

    ESMO 2014 Congress

    26th - 30th September
    Find out the latest news about Boehringer Ingelheim's treatments in oncology.

    Education Hub




    Nintedanib* Lume-Lung
    1 Clinical Trial


    Afatinib* Lux-Lung 3 & 6
    Clinical Trials

    Tweets from @Boehringer